Stocktoria

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA

NYSE · stock · Pharmaceutical Preparations · website · IPO 1951-01-01

TEVA PHARMACEUTICAL INDUSTRIES LTD statistics & valuation

Market cap$119.6B
P / E84.8×
P / S6.9×
P / B15.1×
Net margin8.2%
Return on equity17.8%
Return on capital7.9%
Graham number -63%$13.61

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($13.61); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
1.50% -72.70% -11.80% -5.90% -24.00% 2.60% -16.40% -3.50% -9.90% 8.20% 2016201720182019202020212022202320242025
Gross margin (%)
53.20% 47.40% 45.40% 44.60% 46.40% 47.80% 46.70% 48.20% 48.70% 51.80% 2016201720182019202020212022202320242025
Operating margin (%)
9.80% -78.10% -9.00% -2.60% -21.40% 10.80% -14.70% 2.70% -1.80% 12.50% 2016201720182019202020212022202320242025
Return on equity (%)
0.90% -86.80% -13.60% -6.60% -36.10% 3.70% -28.40% -6.90% -30.50% 17.80% 2016201720182019202020212022202320242025
Shares outstanding
1.12B 1.02B 1.09B 1.09B 1.10B 1.11B 1.11B 1.12B 1.13B 1.16B 2016201720182019202020212022202320242025
Net debt ($)
$31.54B $27.87B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
0.40% -23.00% -3.50% -1.70% -7.90% 0.90% -5.60% -1.30% -4.20% 3.50% 2016201720182019202020212022202320242025
Free cash flow margin (%)
13.60% 6.00% 9.80% 1.30% 3.80% 1.50% 7.00% 2016201720182019202020212022202320242025
Debt / equity (×)
0.93× 1.54× 2016201720182019202020212022202320242025
EPS ($)
$0.07 -$16.26 -$2.35 -$0.91 -$3.64 $0.38 -$2.20 -$0.50 -$1.45 $1.21 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

TEVA PHARMACEUTICAL INDUSTRIES LTD trades at about 30.4× earnings — near its 10-year norm (10-year range 14.6×–477.6×, median 28.2×).

14.6× 477.6×

Shaded band = 10-year range (14.6×–477.6×); dot = today's 30.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin51.8%48.7%48.2%46.7%47.8%46.4%44.6%45.4%47.4%53.2%
Operating margin12.5%-1.8%2.7%-14.7%10.8%-21.4%-2.6%-9.0%-78.1%9.8%
Net margin8.2%-9.9%-3.5%-16.4%2.6%-24.0%-5.9%-11.8%-72.7%1.5%
FCF margin———7.0%1.5%3.8%1.3%9.8%6.0%13.6%
Return on assets3.5%-4.2%-1.3%-5.6%0.9%-7.9%-1.7%-3.5%-23.0%0.4%
Return on equity17.8%-30.5%-6.9%-28.4%3.7%-36.1%-6.6%-13.6%-86.8%0.9%
Debt / equity————————1.54×0.93×
Current ratio1.040.981.021.051.140.990.980.960.860.93

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.